Aminov Erez 4
4 · MIRA PHARMACEUTICALS, INC. · Filed Nov 27, 2024
Insider Transaction Report
Form 4
Aminov Erez
DirectorCEO and Chairman
Transactions
- Sale
Common Stock
2024-11-19$1.39/sh−55,410$77,020→ 1,105,790 total - Sale
Common Stock
2024-11-20$1.27/sh−44,590$56,629→ 1,061,200 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.